Literature DB >> 3129701

Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae.

J Schwartz1, G Shklar, S Reid, D Trickler.   

Abstract

An extract of Spirulina-Dunaliella algae was shown to prevent tumor development in hamster buccal pouch when a 0.1% solution of 7,12-dimethylbenz[a]anthracene (DMBA) in mineral oil was applied topically three times weekly for 28 weeks. The algae extract was delivered by mouth in continued dosages of 140 micrograms in 0.4 ml mineral oil three times per week. After 28 weeks, the animals given vehicle and untreated controls all presented gross tumors of the right buccal pouch. Animals fed canthaxanthin presented a notably and statistically significant reduction in tumor number and size compared with controls. Animals fed beta-carotene demonstrated a smaller but statistically significant reduction in tumor number and size. The algae animals presented a complete absence of gross tumors. However, microscopic sections of the buccal pouch in the algae group showed localized areas of dysplasia and early carcinoma-in-situ undergoing destruction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3129701     DOI: 10.1080/01635588809513979

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  17 in total

Review 1.  Oral oncoprevention by phytochemicals - a systematic review disclosing the therapeutic dilemma.

Authors:  Sujana Mulk Bhavana; Chintamaneni Raja Lakshmi
Journal:  Adv Pharm Bull       Date:  2014-08-25

2.  The optimization of serum-free medium for the production of the scu-PA by the addition of algal extracts.

Authors:  H G Kim; K D Sung; M S Ham; K H Chung; K H Chung; H Y Lee
Journal:  Cytotechnology       Date:  1995-10       Impact factor: 2.058

3.  Differential Reactivity of [beta]-Carotene Isomers from Dunaliella bardawil Toward Oxygen Radicals.

Authors:  C. Jimenez; U. Pick
Journal:  Plant Physiol       Date:  1993-02       Impact factor: 8.340

4.  Spirulina and pentoxyfilline - a novel approach for treatment of oral submucous fibrosis.

Authors:  Bhavana Sujana Mulk; Prasannasrinivas Deshpande; Nagalakshmi Velpula; Vani Chappidi; Raja Lakshmi Chintamaneni; Stuti Goyal
Journal:  J Clin Diagn Res       Date:  2013-12-15

5.  Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis.

Authors:  T Mishima; J Murata; M Toyoshima; H Fujii; M Nakajima; T Hayashi; T Kato; I Saiki
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

6.  Long-term effect of Spirulina platensis extract on DMBA-induced hamster buccal pouch carcinogenesis (immunohistochemical study).

Authors:  Mohammed E Grawish; Ahmed Ragheb Zaher; Ashraf I Gaafar; Wesam A Nasif
Journal:  Med Oncol       Date:  2009-01-21       Impact factor: 3.064

7.  Perchloric acid-soluble proteins from goat liver inhibit chemical carcinogenesis of Syrian hamster cheek-pouch carcinoma.

Authors:  F Ghezzo; G N Berta; B Bussolati; A Bosio; G Corvetti; F Di Carlo; G Bussolati; R Guglielmone; A Bartorelli
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

8.  Biofunctionalized nanofibers using Arthrospira (Spirulina) biomass and biopolymer.

Authors:  Michele Greque de Morais; Christopher Stillings; Roland Dersch; Markus Rudisile; Patrícia Pranke; Jorge Alberto Vieira Costa; Joachim Wendorff
Journal:  Biomed Res Int       Date:  2015-01-15       Impact factor: 3.411

9.  Inhibitory Effect of Spirulina maxima on the Azoxymethane-induced Aberrant Colon Crypts and Oxidative Damage in Mice.

Authors:  Isela Álvarez-González; Víctor Islas-Islas; Germán Chamorro-Cevallos; Juan Pablo Barrios; Norma Paniagua; Verónica R Vásquez-Garzón; Saúl Villa-Treviño; José Antonio Morales-González; Eduardo Madrigal-Bujaidar
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

10.  Spirulina in clinical practice: evidence-based human applications.

Authors:  P D Karkos; S C Leong; C D Karkos; N Sivaji; D A Assimakopoulos
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.